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Statistical analysis in RStandard methodology for identifying chemical carcinogens is both time-consuming and resource intensive. Re-
searchers are actively investigating hownew technologies can be used to identify chemical carcinogens in amore
rapid and cost-effective manner. Here we performed a toxicogenomic case study of the liver carcinogen furan.
Full study and mode of action details were previously published in the Journal of Toxicology and Applied Phar-
macology. Female B6C3F1 mice were sub-chronically treated with two non-carcinogenic (1 and 2 mg/kg bw)
and two carcinogenic (4 and 8 mg/kg bw) doses of furan for 21 days. Half of the mice in each dose group were
also treated with 0.02% bromodeoxyuridine (BrdU) for ﬁve days prior to sacriﬁce [13]. Agilent gene expression
microarrayswere used tomeasure changes in liver gene and long non-coding RNA expression (published in Tox-
icological Sciences). Here we describe the experimental and quality control details for the microarray data. We
also provide the R code used to analyze the raw data ﬁles, produce fold change and false discovery rate (FDR) ad-
justed p values for each gene, and construct hierarchical clustering between datasets.
Crown Copyright © 2014 Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).SpeciﬁcationsOrganism B6C3F1 mice
Sex Female
Array type Agilent SurePrint G3 Mouse GE 8x60K Microarray
Data format
(in GEO)Raw data: TXT ﬁles; normalized data: TXT ﬁlesExperimental
factorsFuran exposed vs. un-exposed controlExperimental
featuresFemale B6C3F1 mice were sub-chronically exposed for 21 days
to control (0 mg/kg bw), non-carcinogenic (1, 2 mg/kg bw), and
carcinogenic (4, 8 mg/kg bw) doses of furan. Half of the mice in
each group were also given 0.02% BrdU for ﬁve days prior to
sacriﬁce (days 16–21). All non-BrdU mice as well as the 0, 1, and
8 mg/kg bw furan + BrdU mice were used for gene expression
analysis. Necropsy occurred four hours after the ﬁnal furan dosing.
RNA was extracted from livers and changes in gene expression
were analyzed using Agilent microarrays.ce and Research Bureau, ERHSD,
03A), 50 Colombine Driveway,
fax: +1 613 941 8530.
ebster),
.com (L. Recio),
r Inc. This is an open access article undSpeciﬁcations (continued)
SpeciﬁcationsConsenter the CC BY-NC-NAll procedures were conducted in compliance with the Animal
Welfare Act Regulations (9CFR1–4). Mice were handled and
treated according to the guidelines provided in the National
Institutes of Health (NIH) Guide for the Care andUse of Laboratory
Animals (ILAR, 1996; http://dels.nas.edu/ilar/).Sample source
location5–6 week old female speciﬁc pathogen free B6C3F1 mice were
purchased from Charles River Breeding Laboratories (Portage, ME).
Experiments were conducted at ILS, P.O. Box 13501, Research
Triangle Park, NC 27709, USA.Direct link to deposited data
The complete dataset is available through the Gene Expression
Omnibus.
Non-BrdU dataset: http://www.ncbi.nlm.nih.gov/geo/query/acc.
cgi?acc=GSE48644
BrdU dataset: http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?
acc=GSE54078D license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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Fig. 1.A representativeMA plot for (A) before and (B) after LOWESS normalization. Each dot represents a probe on themicroarray. The red line is the line of best ﬁt through all data points.
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Study design
5–6 week old female speciﬁc pathogen free B6C3F1 mice were pur-
chased from Charles River Breeding Laboratories (Portage, ME) and
were allowed to acclimatize for at least seven days prior to the start of
the study. Feed (NIH-07; Zeigler Brothers, Inc., Gardners, PA) and tap
water were available ad libitum up until the time of necropsy. Mice
were housed ﬁve per cage in polycarbonate cages in a speciﬁc pathogen
free (SPF) and Association for Assessment and Accreditation of
Laboratory Animal Care (AAALAC) accredited facility.
Female mice were dosed with furan (CAS no. 110-00-9) (N99%
pure) (Sigma-Aldrich Chemical Co., Milwaukee, WI) in Mazola corn
oil at 0, 1, 2, 4, or 8 mg/kg bw per day by oral gavage for three
weeks (n = 10 per dose groups). Upon necropsy, there remained n =
5 mice in each non-BrdU dose group. However, some mice were lost
due to early (pre-BrdU treatment) mis-dosing or esophageal puncture,
therefore the 0, 1, 2, 4, or 8 mg/kg bw+ BrdU groups had n= 4, 5, 3, 4,
or 5 mice, respectively. +BrdU mice were treated with 0.02% BrdU
(Sigma Chemical Co., St. Louis, MO, USA) in drinking water for ﬁve
days prior to sacriﬁce. Four hours after their ﬁnal dosing, mice were
anesthetized by carbon dioxide inhalation prior to euthanasia by
exsanguination achieved by cutting the caudal vena cava after blood
collection. One animal per group was killed and this continued until
all mice had been sacriﬁced; this occurred over a period of 100 min
(beginning at 1 pm). The left, median, right posterior and right anterior
lobes of the liver were cut into 0.25–0.5 cm3 pieces that were either
snap-frozen in liquid nitrogen and stored at or below−70 °C or were
formalin ﬁxed and parafﬁn embedded.
Microarray: sample labeling and hybridization
RNA was extracted from ~100 mg frozen liver tissue using the
RNeasy Midi RNA Extraction kit (Qiagen, Mississauga, ON, Canada). An
Omni tissue homogenizer with a disposable 7 mm Omni generator
probe was used (Omni #34750, Omni International, Marietta, GA).RNA was quantiﬁed using a NanoDrop Spectrophotometer (Thermo
Fisher Scientiﬁc Inc., Wilmington, DE, USA), qualiﬁed using an Agilent
2100 Bioanalyzer (Agilent Technologies Inc., Mississauga, ON, Canada),
and stored at −80 °C. Sample RNA integrity numbers (RINs) ranged
from 8.9–10.
Sample RNA (200 ng) was used together with a mouse universal
reference RNA (Stratagene by Agilent Technologies Inc.) to synthesize,
amplify and label cRNA using the Low Input Quick Amp Labeling Kit
(Agilent Technologies Inc.). Labeled cRNA was puriﬁed using the
RNeasy Mini Kit (Qiagen). Ampliﬁcation and labeling efﬁciency of
cRNAwere quantiﬁed using aNanoDrop spectrophotometer. Hybridiza-
tion mixes were prepared using the Hi-RPM Gene Expression Hybridi-
zation Kit (Agilent Technologies Inc.). 300 ng of Cy3-labeled reference
RNAand 300ngCy5-labeled sample cRNAwere hybridized on SurePrint
G3 Mouse GE 8 × 60 K microarrays (Agilent Technologies Inc.) at 65 °C
for 17 h at 10 rpm. Samples were arranged on arrays according to a ran-
domized block design (RBD). An RBD is used to control for a source of
variability that is not related to the experimental question. Themicroar-
ray slides used in this experiment each had eight arrays, which means
that a total of eight samples could be hybridized to each slide. Since
this experiment had more than eight samples, there were two blocking
factors that could impact the results: (1) which slide the samples
appeared on, and (2) which array the sample was assigned to (i.e. the
sample's location on a microarray slide, of which there are eight
options). All samples (control, treated, ±BrdU) were randomized
across ﬁve slides. Slides were washed according to the manufacturer's
speciﬁcations with Gene Expression Wash Buffers 1 and 2 (Agilent
Technologies Inc.), scanned using an Agilent G2505B scanner at 5 μm
resolution.Datawere pre-processed using theAgilent Feature Extraction
Software, version 11. All arrays met the minimum Agilent QA/QC
standards. All kits were carried out according to the manufacturer's
protocol.
Normalization of microarray data
Boxplots of the relative ratio and signal intensities (MA plots) were
constructed and inspected. MA plots are used to identify systematic
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within arrays. ‘M’ is the log red/green intensity ratio (log(R/G), a
measure of differential gene expression) and ‘A’ is the average log of
the product of the two intensities (log(R⁎G), a measure of overall
ﬂuorescence intensity). Since the majority of probes are not expected
to be differentially expressed in response to the treatment, themajority
of points on the y-axis (M) should fall at zero. Data where the majority
of points on the y-axis are not at zero must be LOWESS (LOcally
WEighted Scatterplot Smoothing) normalized [10] (Fig. 1). Non-
background-subtracted median signal intensities were normalized in
R [7] using the transform.madata function in the MAANOVA library
[9]. Probes with technical replicates were then averaged.
Quality assessment and control of microarray data
The background for each array was assessed using the negative con-
trol 3xSLv1 probe, which forms a hair pin and does not hybridize well
with labeled samples. There are 182 technical replicates of this probeFig. 2. Background estimates of each array for reference (Cy3, green) and sample (Cy5, red)
bars = standard deviation; FLU = ﬂuorescent units.distributed across the microarray. The trimmed mean (trim = 0.05)
and standard deviation was used to measure the background
ﬂuorescence and background variability for each array. Using trimmed
statistics reduces the effects of outliers that may be present. This is
done by removing a percentage of the largest and smallest values before
calculating the statistics. Fig. 2 provides a visual representation of these
estimates. Arrays with background ﬂuorescence that fell outside of
these ranges were repeated.
To identifymicroarrayswith poor data quality, hierarchical clustering
analysis with average linkage (a method for calculating distance
between clusters that averages over all pairs of objects between
two clusters) was performed in R software (hclust function in the
stats library) using the normalized log ratios (M values) for all
probes (Fig. 3). Since the majority of probes will not be differentially
expressed in response to the treatment, the expectation is that there
will be no differences between samples. To obtain a fair inter-array
comparison, signal intensities were adjusted to control for slide effect
(i.e. to control for slide-to-slide variation in signal intensity that occursmean ﬂuorescent signal of the 3xSLv1 negative control probe (n= 182 probes). Error
O
ut
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Fig. 3.Hierarchical clustering of all probes based onnormalized signal intensity ratios. The red line and bracket delineate outlier arrays, whichwere repeated (repeated arrays are indicated
by arrows). Colored boxes represent dose groupswhere orange, lime, green, aqua-green, and light blue are the 0, 1, 2, 4, and 8 mg/kg bwgroups; and, royal blue, purple, and pink are the 0,
1, and 8 mg/kg bw+ BrdU groups.
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treatment-related effect) using a linear model, which subtracted the
estimated slide effect from the log ratios. One minus the Pearson
correlation was used as the measure of dissimilarity. The original
dendrogram was cut at 0.3, which has 6 clusters. The 5 samples that
clustered separately (at the top) were considered outliers and were
then repeated.
Upon repetition and/or removal of outlying arrays (arrays with high
background, systematic dye variation, or poor hybridization efﬁciency),
theﬁnal sample sizes used for gene expression analysis were n=5, 4, 5,
4, and 5 for the non-BrdU 0, 1, 2, 4, and 8 mg/kg bw furan dose groups,
respectively; and n= 4, 5, 5 for the 0, 1, and 8 mg/kg bw furan+ BrdU
groups, respectively. Gene expression analysis was not conducted for
the 2 and 4 mg/kg furan + BrdU animals.Differential gene expression analysis
Differential gene expressionwas determined in R using theMicroArray
ANalysis Of VAriance (MAANOVA) library [9]. Included in the
MAANOVA model are the block (slide) and the treatment effects. A
typical ANOVA generates an F statistic, which is the ratio of inter- to
intra-group variance. The MAANOVA uses a modiﬁed F statistic, called
an Fs statistic [3], to determine gene-speciﬁc treatment effects. Using
the James–Stein shrinkage concept [6], the Fs statistic has an improved
estimation of error variance because it estimates intra-group variance
based on global gene expression (as opposed to expression of individual
genes, which have far fewer data points associated with them). The as-
sociated p-values were then estimated using the permutation method
(i.e. bootstrapping) with 30,000 permutations and residual shufﬂing.
Experimental Design: 
Randomized block design
Agilent Oligonucleotide Microarrays: 
Sample labeling and hybridizaon
Data pre-processing:
Feature Extracon from .f array image ﬁles
Quality assessment and control:
MA plots
Array background assessment (3xSLv1 probe)
Hierarchical clustering of samples based on all probes
Differential gene expression analysis:
MicroArray ANalysis Of VAriance (MAANOVA) in R
Are 
there 
outliers?
Data normalization:
LOWESS (LOcally WEighted Scaerplot Smoothing) in R
Fig. 4. Summary of steps taken to generate, normalize and analyze two-color Agilent gene expression microarray data.
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pression associated p-values because the typical sample size for gene
expression studies is quite low (n = ~3–6 per group). The p-values
were adjusted formultiple comparisons using the Benjamini–Hochberg
false discovery rate (FDR) approach [1]. This approach sets amore strin-
gent signiﬁcance threshold ofα=0.05 for all comparisons (as opposed
to α=0.05 for individual comparisons, which would result in a higher
false positive rate). Individual gene fold changes were estimated using
least square means of each pairwise comparison. Genes having an
FDR-adjusted p≤ 0.05 and a fold change≥±1.5were deemed differen-
tially expressed.Gene expression meta-analysis in R
Data were obtained from Gene Expression Omnibus (http://www.
ncbi.nlm.nih.gov/geo/) and the European Bioinformatics Institute
(http://www.ebi.ac.uk/arrayexpress/). All data generated using the
one-color Affymetrix platform (E-MEXP-82; GSE13149; GSE18858;
GSE20427; GSE26538) were background-subtracted and normalized
using RobustMulti-array Average, RMA [12], using the ReadAffy() func-
tion in the affy library in R [4]. Since the RMA requires background sub-
traction, data generated by all other platforms were also background
subtracted for consistency. Signal intensities generated on the Agilent
two-color platform (GSE48644; BaP) were normalized using the
LOWESS approach. For two-color experiments using other, non-
Agilent platforms (GSE35934; GSE4874), signal intensities (with a dye
adjustment) were normalized using cyclic LOWESS [2]. Normalized
probe intensities for probes with common gene symbols were then av-
eraged using the median normalized signal intensity. Normalized data
from each data set were then merged together yielding 3190 common
gene symbols. Hierarchical clustering was conducted using the hclust
function with average linkage using one minus the Pearson correlation
as the distance metric in R. The relevant ﬁgure can be viewed in [5].Discussion
Here we have described the steps taken to analyze changes in gene
expression in the livers of furan-exposed female B6C3F1 mice using
Agilent microarrays and R (see Fig. 4 for summary). We have
demonstrated that the data are of high quality and have provided all
of the tools required for reproducibility. The biological signiﬁcance of
the study was previously reported: differential gene expression [5],
differential long non-coding RNA expression [8], and effect of BrdU on
gene expression [11]. We anticipate that the importance of
toxicogenomics studies in chemical carcinogen assessment will contin-
ue to increase in the coming years and believe that the rate atwhich this
occurs will be highly dependent upon ensuring public availability of
these very powerful datasets.
Appendix A. Supplementary data
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.gdata.2014.05.013.
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